Insightful analysis of Albemarle’s July insider buying shows directors backing the company’s lithium‑and‑specialty‑chemistry shift, hinting at long‑term upside.
Albemarle insider buys signal confidence: small, steady trades show management believes the stock is undervalued, backed by strong lithium‑battery growth and solid fundamentals.